93 related articles for article (PubMed ID: 2873619)
61. Do anticholinergic antagonize antipsychotic drug action?
Ziemba T; Meltzer HY; Davis JM
Schizophr Bull; 1978; 4(1):7-12. PubMed ID: 34210
[No Abstract] [Full Text] [Related]
62. Clozapin in psychomotor instability. A controlled study.
Výborová L; Náhunek K; Balastíková B; Misurec J
Act Nerv Super (Praha); 1978 Dec; 20(4):274-5. PubMed ID: 367039
[No Abstract] [Full Text] [Related]
63. [Studies on the treatment of chronic simple schizophrenia with haloperidol].
Kaczyński M; Bernaśkiewicz E; Wypych M; Wojnicka H
Neurol Neurochir Psychiatr Pol; 1965; 15(2):281-7. PubMed ID: 5320012
[No Abstract] [Full Text] [Related]
64. Lithium withdrawal trial in chronic schizophrenia.
Delva NJ; Letemendia FJ; Prowse AW
Br J Psychiatry; 1982 Oct; 141():401-6. PubMed ID: 6129017
[No Abstract] [Full Text] [Related]
65. An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
McEvoy JP
CNS Spectr; 2006 Jul; 11(7 Suppl 7):4-8. PubMed ID: 16816794
[No Abstract] [Full Text] [Related]
66. [Comparative analysis of haloperidol effect on depressive states in the early patients].
Alkhimova LN
Vrach Delo; 1978 May; (5):150-4. PubMed ID: 354210
[No Abstract] [Full Text] [Related]
67. Changes in staff anxiety and attitudes during a double blind study of haloperidol in acute schizophrenics within a structured milieu.
Singh MM; Di Scipio WJ
J Nerv Ment Dis; 1972 Oct; 155(4):245-56. PubMed ID: 4561348
[No Abstract] [Full Text] [Related]
68. Antipsychotic effect of gamma-type endorphins in schizophrenia.
van Ree JM; de Wied D; Verhoeven WM; van Praag HM
Lancet; 1980 Dec 20-27; 2(8208-8209):1363-4. PubMed ID: 6109172
[No Abstract] [Full Text] [Related]
69. [Logical analysis of the respective influence of 3 experimental variables using a diagram by L. Carroll. Application of this method to a clinical trial of 2 forms of Noveril].
Mormont C
Acta Psychiatr Belg; 1975 Jan; 75(1):93-105. PubMed ID: 8956
[TBL] [Abstract][Full Text] [Related]
70. Use of verapamil to treat negative symptoms in schizophrenia.
Price WA; Pascarzi GA
J Clin Psychopharmacol; 1987 Oct; 7(5):357. PubMed ID: 3680609
[No Abstract] [Full Text] [Related]
71. Somatic profiles in chronic schizophrenia.
Howard JS
Psychosomatics; 1976; 17(1):26-31. PubMed ID: 5744
[No Abstract] [Full Text] [Related]
72. Haloperidol in barbiturate detoxification.
Snyder R
Mil Med; 1977 Nov; 142(11):885-6. PubMed ID: 412133
[No Abstract] [Full Text] [Related]
73. Methodological issues of hemodialysis in schizophrenia.
Schulz SC; van Kammen DP
Psychopharmacol Bull; 1979 Oct; 15(4):15-7. PubMed ID: 390596
[No Abstract] [Full Text] [Related]
74. Comparison of haloperidol and thioridazine in geriatric outpatients.
Solomon K
J Clin Psychiatry; 1979 Nov; 40(11):495. PubMed ID: 489533
[No Abstract] [Full Text] [Related]
75. A comparison of drug-trial schizophrenics with their clinical counterparts.
Guy W; Cleary P; Switalski R
Psychopharmacol Bull; 1977 Jul; 13(3):44-5. PubMed ID: 887714
[No Abstract] [Full Text] [Related]
76. Haloperidol's introduction in the United States: A tale of a failed trial and its consequences.
Tavares J
J Hist Neurosci; 2024; 33(2):169-179. PubMed ID: 38091571
[TBL] [Abstract][Full Text] [Related]
77. The application of hepatocyte culture to the identification of pathways of drug metabolism: studies with pindolol and fluperlapine.
Paine AJ; Maurer G; von Wartburg BR
Biochem Pharmacol; 1984 Oct; 33(19):3111-4. PubMed ID: 6148946
[No Abstract] [Full Text] [Related]
78. Frustrations with clinical trials.
Sherry S
Eur J Clin Pharmacol; 1980 Feb; 17(2):79-80. PubMed ID: 7371708
[No Abstract] [Full Text] [Related]
79. Double-blind trials.
Newcombe RG
Br J Psychiatry; 1990 Feb; 156():282. PubMed ID: 2180531
[No Abstract] [Full Text] [Related]
80. Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.
Migler BM; Warawa EJ; Malick JB
Psychopharmacology (Berl); 1993; 112(2-3):299-307. PubMed ID: 7871034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
